Rare diseases
Investigational molecules
Locations
Back to Germany121 clinical trials in Bremen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
GermanyA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
GermanyStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
GermanyStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyStudy of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies
GermanyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
GermanyStudy on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery
GermanyStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Acute Myeloid Leukemia (AML) and Chronic Myeloid Leukemia, investigating novel combination therapies and treatment approaches for patients ineligible for intensive chemotherapy.
Comprehensive studies examining various types of breast cancer treatments, with particular focus on triple-negative and HR+/HER2- breast cancers. Research includes evaluation of immunotherapy and targeted therapeutic approaches.
Innovative research targeting atherosclerotic cardiovascular disease and hypertension, exploring new treatment methods including cholesterol management and blood pressure control techniques.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
